Tag: progression-free survival

A retrospective cohort of 331 initially diagnosed patients with HCC and Vp3/4 portal vein tumor thrombosis found a 61.3% objective ...

A retrospective study of 109 patients finds that CD19-directed CAR T-cell therapy reduces nodal and extranodal lymphoma tumors to a ...

The phase III TAISHAN-302 trial found that the anti-B7-H3 antibody-drug conjugate Tam-Peli reduced the risk of death by 54 percent ...

A meta-analysis of six randomized trials found that adding PD-1/PD-L1 inhibitors to chemotherapy was associated with longer progression-free and overall ...

In the phase 3 REZILIENT 3 trial, adding zipalertinib to platinum-pemetrexed chemotherapy extended median progression-free survival from 8.5 to 14.5 ...

A retrospective study of 47 patients found that high folate receptor alpha expression was independently associated with shorter progression-free survival ...

A single-center cohort study linked checkpoint inhibitor-containing therapy with longer unadjusted progression-free survival in advanced SMARCA4-deficient thoracic tumors, but adjusted ...

A meta-analysis of fourteen retrospective cohort studies associates TACE-HAIC combined with targeted therapy and immune checkpoint inhibitors with improved survival ...

A French early-access program of 3,709 patients with metastatic castration-resistant prostate cancer found that 177Lu-PSMA-617 produced efficacy and safety outcomes ...

A real-world cohort study of 327 patients with EGFR-mutated non-small cell lung cancer finds that continuing EGFR-TKI therapy plus anti-angiogenic ...

A retrospective MD Anderson cohort of nine adults with NF1-associated high-grade glioma found partial radiographic responses in two patients treated ...

In a multicenter retrospective cohort of 69 patients with refractory metastatic colorectal cancer, an initial fruquintinib dose below 5 mg ...

A retrospective Nepalese cohort of 31 patients associated 20- or 40-milligram nivolumab with responses across advanced cancers, but uncontrolled evidence ...

An exploratory BRIGHT-2 trial analysis associated longitudinal ctDNA patterns with prognosis, molecular response and candidate resistance alterations in advanced breast ...

A six-center retrospective study of 275 osimertinib-treated patients associated postoperative recurrence with longer progression-free and overall survival than de novo ...

A retrospective analysis of 154 patients with unresectable hepatocellular carcinoma found that low baseline handgrip strength was associated with shorter ...

A 37-patient retrospective cohort found that immune checkpoint inhibitor–containing chemoimmunotherapy was associated with longer overall survival than chemotherapy alone in ...

A Nepal single-centre retrospective study characterized 51 ALK- or ROS1-positive cases, including 49 non-small cell lung cancers and two inflammatory ...

A retrospective single-center study found that at least 20% early tumor shrinkage was associated with longer progression-free survival after first-line ...

A retrospective single-center cohort of 128 patients associated frontline bevacizumab with longer overall survival in advanced ovarian cancer, while clear ...